Retraction Note: Diagnostic and prognostic value of plasma microRNA-195 in patients with non-small cell lung cancer.

Keli Su, Tingcui Zhang, Yongrui Wang, Guijun Hao

RetractedOpen access · goldAbstract readRetraction Notice

In one paragraph

Article in World journal of surgical oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

0.2field-weighted citation impact, top 55% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

microRNA-195 Promotes Small Cell Lung Cancer Cell Apoptosis via Inhibiting Rap2C Protein-Dependent MAPK Signal Transduction.Technology in cancer research & treatment
Article

4 · The record

Corrections and comments

Retraction of
Diagnostic and prognostic value of plasma microRNA-195 in patients with non-small cell lung cancer.2016

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Keli SuDepartment of Oncology, The Fourth People's Hospital of Jinan, NO. 50, Shifan Road, Jinan, 250031, Shandong Province, China.

Tingcui ZhangDepartment of Internal Medicine, The Central Hospital of Jinan, Jinan, 250012, Shandong Province, China.

Yongrui WangDepartment of Clinical Laboratory, The Fourth People's Hospital of Jinan, Jinan, 250031, Shandong Province, China.

Guijun HaoDepartment of Oncology, The Fourth People's Hospital of Jinan, NO. 50, Shifan Road, Jinan, 250031, Shandong Province, China. manuhaogj@163.com.

Fourth People’s Hospital of Jinan · CNJinan Central Hospital · CNThe Fourth People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This article [1] is retracted at the request of Editor-in-Chief due to overlap with articles [2-5].None of the authors have responded to any correspondence from the editor or publisher about this retraction.

Identifiers

PMID31291954

DOI10.1186/s12957-019-1664-y

PMCPMC6621957

OpenAlexW2529949819

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.